Cover Image
市場調查報告書

腎臟醫療設備及服務的全球市場:成長,趨勢及預測(2017年∼2022年)

Global Renal Medical Devices & Services Market - Growth, Trends & Forecast (2017 - 2022)

出版商 Mordor Intelligence LLP 商品編碼 391362
出版日期 內容資訊 英文 205 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
腎臟醫療設備及服務的全球市場:成長,趨勢及預測(2017年∼2022年) Global Renal Medical Devices & Services Market - Growth, Trends & Forecast (2017 - 2022)
出版日期: 2017年01月24日 內容資訊: 英文 205 Pages
簡介

由於腎臟疾病在世界範圍內發病率高,因此腎臟和相關腎臟系統在較長時期內功能逐漸喪失正助長市場。

本報告提供全球腎臟醫療設備及服務市場調查,整體市場趨勢,產品、各地區的詳細趨勢,市場成長的影響要素分析,競爭情形,主要企業簡介等,總括性彙整。

目錄

第1章 簡介

  • 關於報告
  • 調查方法

第2章 摘要整理

第3章 市場概要

  • 市場定義
  • 市場成長要素
    • 腎臟病發病率的增加
    • 糖尿病,高血壓的增加
    • 高齡人口
    • 最新治療的需求高漲
    • 意識的提高和合理的價格
  • 市場阻礙因素
    • 償付問題
    • 缺乏意識的地區的存在

第4章 波特五力分析

  • 供應商談判力
  • 買主談判力
  • 競爭程度
  • 替代品的威脅
  • 新加入廠商的威脅

第5章 市場區隔

  • 各類型
    • 透析設備
    • 腎交感神經去除術設備
    • 穿戴式人工腎臟設備
    • 遠位栓塞保護裝置
  • 各應用領域
    • 腎功能衰竭
    • 慢性腎臟病
    • 末期腎臟疾病
    • 腎臟結石症
    • 高血壓
    • 糖尿病
    • 貧血
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
      • 印度
      • 中國
      • 日本
      • 新加坡
      • 其他地區

第6章 競爭情形

第7章 企業簡介

  • Fresenius Medical
  • DaVita Healthcare Partners, Inc.
  • Baxter International, Inc.
  • B. Braun Melsungen AG
  • Nipro
  • Covidien
  • Infomed SA
  • Medtronic
  • St. Jude Medical, Inc
  • Boston Scientific Corporation

第8章 附錄

  • 簡稱
  • 參考文獻
  • 免責聲明

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Description

The global renal medical devices & services market generated a revenue of about $XX billion in 2015 and is anticipated to grow up to $XX billion at a CAGR of XX% by 2020.

Renal disease, a progressive loss of proper functioning of the kidneys and associated renal system over a longer period of time is fueling the market because of its high incidence rate worldwide.

The market for global renal medical devices & services are segmented on the basis of 1) Type (Dialysis equipment which further includes Peritoneal Dialysis equipment, hemodialysis equipment, hemofiltration equipment, hemodiafiltration equipment, intestinal dialysis equipment and CRRT), Renal Denervation devices, Wearable artificial kidney and distal embolic protection devices 2) Application ( kidney failure, chronic kidney disease, end-stage kidney disease, Renal kidney stone disease, hypertension, diabetes, and anemia) and 3) Geographical Terrains.

Patients with kidney disease can now look forward for innovative technologies and treatment concepts like modern dialysis methods for best possible quality of life. Medical support by reimbursement and funding for renal diseases especially ESRD has a substantial share of health expenditure. Governments around the world are using various reimbursement strategies depending upon the type of dialysis and medical condition, there by balancing cost and quality care.

Geographically, North America holds the leading position for this market and Europe is found almost closer to it. Asia Pacific region is expected to show high growth in the near future due to increasing number of diabetic and high blood pressure patients that ultimately lead to kidney disease, rising healthcare awareness and increasing demand for advanced diagnostics and therapeutics for renal diseases.

Some of the major players operating in the renal medical devices & services market are Fresenius Medical (Germany), DaVita Healthcare Partners, Inc. (U.S.), Gambro AB (Sweden), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Nipro Corporation (Japan), Medical Components, Inc. (U.S.), Covidien (Ireland), NxStage Medical, Inc. (U.S.), Infomed SA (Switzerland), Nikkiso Co., Ltd (Japan), Medtronic(US), St. Jude Medical, Inc.(US),Boston Scientific Corporation and others.

Drivers

The growth of the market for global renal medical devices & services is fueled by factors like increasing incidences of kidney diseases worldwide, increasing number of individuals suffering from diabetes, high blood pressure etc., aging population, rising demand for advanced therapeutics for the disease and increasing awareness and affordability of the people.

Restraints

The factors constraining growth of this market majorly include reimbursement issues and low awareness about kidney disease in some regions.

What the report offers?

1) Market Definition for the specified topic along with identification of key drivers and restraints for the market.

2) Market analysis for Global Stem Cell Banking Market in Healthcare Industry, with region specific assessments and competition analysis on a global and regional scale.

3) Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.

4) Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.

5)Identification and analysis of the Macro and Micro factors that affect the Global Stem Cell Banking Market in Healthcare Industry on both global and regional scale.

6) A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Table of Contents

1. Introduction

  • 1.1 Report Description
  • 1.2 Research Methodology

2. Executive Summary

3. Market Overview

  • 3.1 Market Definition
  • 3.2 Market Drivers
    • 3.2.1 Increasing incidences of kidney diseases
    • 3.2.2 Increase in diabetes, high blood pressure conditions
    • 3.2.3 Aging population
    • 3.2.4 Rising demand for advanced therapies
    • 3.2.5 Increasing awareness and affordability
  • 3.3 Market restraints
    • 3.3.1 Reimbursement issues
    • 3.3.2 Lack of awareness in few regions

4. Porters Five Force Analysis

  • 4.1 Bargaining Power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Degree of competition
  • 4.4 Threat of substitution
  • 4.5 Threat of new entrants

5. Market Segmentation

  • 5.1 By Type
    • 5.1.1 Dialysis Equipment
      • 5.1.1.1 Peritoneal Dialysis equipment
      • 5.1.1.1.1 Dialyzer
      • 5.1.1.1.2 Needles
      • 5.1.1.1.3 Catheter
      • 5.1.1.1.4 Dialysate
      • 5.1.1.1.5 Bloodlines
      • 5.1.1.2 Hemodialysis equipment
      • 5.1.1.2.1 Blood tubing set
      • 5.1.1.2.2 Endotoxin Retention Filter
      • 5.1.1.2.3 AV-Access Device and accessories
      • 5.1.1.3 Hemofiltration equipment
      • 5.1.1.4 Hemodiafiltration equipment
      • 5.1.1.5 Intestinal dialysis equipment
      • 5.1.1.6 CRRT
      • 5.1.1.6.1 CRRT disposables
      • 5.1.1.6.2 CRRT dialysate and replacement fluids
      • 5.1.1.6.3 CRRT system
    • 5.1.2 Renal Denervation devices
      • 5.1.2.1 Ultrasound-based renal denervation systems
      • 5.1.2.2 Renal sympathetic denervation devices
      • 5.1.2.3 Radiofrequency-based renal denervation systems
      • 5.1.2.4 Micro-infusion catheter-based renal denervation systems
    • 5.1.3 Wearable artificial kidney device
    • 5.1.4 distal embolic protection devices
      • 5.1.4.1 Filter baskets
      • 5.1.4.2 Distal occlusion balloons
      • 5.1.4.3 Proximal occlusion balloons
  • 5.2 By Application
    • 5.2.1 kidney failure
    • 5.2.2 chronic kidney disease
    • 5.2.3 end-stage kidney disease
    • 5.2.4 Renal kidney stone disease
    • 5.2.5 hypertension
    • 5.2.6 diabetes
    • 5.2.7 anemia
  • 5.3 By Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
    • 5.3.2 Europe
      • 5.3.2.0 France
      • 5.3.2.1 UK
      • 5.3.2.2 Germany
      • 5.3.2.3 Scandinavian Regions
      • 5.3.2.4 Italy
      • 5.3.2.5 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3..1 India
    • 5.3.3..2 China
    • 5.3.3..3 Japan
    • 5.3.3..4 Singapore
    • 5.3.4 Rest of the World

6. Competitive Landscape

7. Company Profiles

  • 7.1 Fresenius Medical
  • 7.2 DaVita Healthcare Partners, Inc.
  • 7.3 Baxter International, Inc.
  • 7.4 B. Braun Melsungen AG
  • 7.5 Nipro Corporation
  • 7.6 Covidien
  • 7.7 Infomed SA
  • 7.8 Medtronic
  • 7.9 St. Jude Medical, Inc
  • 7.10 Boston Scientific Corporation

8. Appendix

  • 8.1 Abbrevations
  • 8.3 Bibliography
  • 8.4 Disclaimer
Back to Top